Evidence map›Paper›PMID 35328122›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Convolutional Neural Network-Based Automatic Analysis of Chest Radiographs for the Detection of COVID-19 Pneumonia: A Prioritizing Tool in the Emergency Department, Phase I Study and Preliminary "Real Life" Results.

Davide Tricarico, Marco Calandri, Matteo Barba, Clara Piatti, Carlotta Geninatti, Domenico Basile, Marco Gatti, Massimiliano Melis, Andrea Veltri

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Davide TricaricoAITEM Artificial Intelligence Technologies Multipurpose s.r.l., Corso Castelfidardo 36, 10129 Turin, Italy.
Marco CalandriDiagnostic and Interventional Radiology Unit, Oncology Department, San Luigi Gonzaga University Hospital, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.
Matteo BarbaDiagnostic and Interventional Radiology Unit, Oncology Department, San Luigi Gonzaga University Hospital, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.ORCID 0000-0002-3295-9625
Clara PiattiDiagnostic and Interventional Radiology Unit, Oncology Department, San Luigi Gonzaga University Hospital, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.
Carlotta GeninattiDiagnostic and Interventional Radiology Unit, Oncology Department, San Luigi Gonzaga University Hospital, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.
Domenico BasileDiagnostic and Interventional Radiology Unit, Oncology Department, San Luigi Gonzaga University Hospital, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.ORCID 0000-0002-7184-5225
Marco GattiRadiology Unit, Department of Surgical Sciences, University of Turin, Città della Salute e della Scienza di Torino, Corso Bramante, 88/90, 10126 Turin, Italy.ORCID 0000-0001-8168-5280
Massimiliano MelisAITEM Artificial Intelligence Technologies Multipurpose s.r.l., Corso Castelfidardo 36, 10129 Turin, Italy.
Andrea VeltriDiagnostic and Interventional Radiology Unit, Oncology Department, San Luigi Gonzaga University Hospital, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.ORCID 0000-0001-7153-063X
University of Turin · ITCollegio Carlo Alberto · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of our study is the development of an automatic tool for the prioritization of COVID-19 diagnostic workflow in the emergency department by analyzing chest X-rays (CXRs). The Convolutional Neural Network (CNN)-based method we propose has been tested retrospectively on a single-center set of 542 CXRs evaluated by experienced radiologists. The SARS-CoV-2 positive dataset (n = 234) consists of CXRs collected between March and April 2020, with the COVID-19 infection being confirmed by an RT-PCR test within 24 h. The SARS-CoV-2 negative dataset (n = 308) includes CXRs from 2019, therefore prior to the pandemic. For each image, the CNN computes COVID-19 risk indicators, identifying COVID-19 cases and prioritizing the urgent ones. After installing the software into the hospital RIS, a preliminary comparison between local daily COVID-19 cases and predicted risk indicators for 2918 CXRs in the same period was performed. Significant improvements were obtained for both prioritization and identification using the proposed method. Mean Average Precision (MAP) increased (p < 1.21 × 10−21 from 43.79% with random sorting to 71.75% with our method. CNN sensitivity was 78.23%, higher than radiologists’ 61.1%; specificity was 64.20%. In the real-life setting, this method had a correlation of 0.873. The proposed CNN-based system effectively prioritizes CXRs according to COVID-19 risk in an experimental setting; preliminary real-life results revealed high concordance with local pandemic incidence.

Indexed as

artificial intelligencechest X-rayConvolutional Neural Network (CNN)coronavirus disease 2019 (COVID-19)deep learningprioritization

Identifiers

PMID35328122
PMCPMC8947382
OpenAlexW4213055567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.